There are 2789 resources available
1393P - Phase I/II clinical trial of combination of anti-PD-1 mAb, nivolumab with radiotherapy for unresectable and recurrent gastric cancer who failed to standard chemotherapy
Presenter: Koji Kono
Session: ePoster Display
1394P - Frequentist and Bayesian analysis of second line treatment effectiveness in AGAMENON-SEOM gastric cancer registry
Presenter: Nieves Martinez Lago
Session: ePoster Display
1395P - Impact of delay in adjuvant chemotherapy on survival in resected gastric cancer: Real world data from India
Presenter: Shalabh Arora
Session: ePoster Display
1396P - Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: An exploratory analysis from the PRODIGY study
Presenter: Hyung-don Kim
Session: ePoster Display
1397P - Prognostic impact of infectious complications: Exploratory analysis of JCOG0501 phase III trial
Presenter: Masato Hayashi
Session: ePoster Display
1328P - Outcomes from local consolidative therapy and immune checkpoint inhibitors in metastatic non-small cell lung cancer
Presenter: Lingzhi Hong
Session: ePoster Display
1329P - A single-arm, open-label, multi-center, phase I study of HA121-28 in patients with advanced solid tumors
Presenter: Hongyun Zhao
Session: ePoster Display
1330P - Second-line nintedanib + docetaxel for patients with lung adenocarcinoma after first-line chemo-immunotherapy treatment: Updated efficacy and safety results from VARGADO Cohort C
Presenter: Christian Grohé
Session: ePoster Display
1385P - Phase II study of neoadjuvant camrelizumab combined with chemoradiation for locally advanced proximal gastric cancer (Neo-PLANET, NCT03631615)
Presenter: Zhao-qing Tang
Session: ePoster Display